Serum Institute gets DCGI nod to conduct phase 2, 3 human trials of Oxford vaccine in 1,600 healthy volunteers in India
Tech2 News Staff • .Serum Institute has partnered with AstraZeneca to manufacture the vaccine, saying in a statement that it will make a billion doses once cleared by regulatory authorities.
